RSS FeedsMedPage Today Endocrinology
http://www.medpagetoday.com/rss/Endocrinology.xml
Physicians.....get the latest breaking news on Endocrinology. Free CME, accredited by the University of Pennsylvannia, is available for physicians and other medical professionals. Total news: 15
Last news: August 30, 2007 17:28:28
|
| Estrogen That Protects The Brain Without Increasing Cancer Risk May Treat MS
August 30, 2007 09:00:00FINDINGS:UCLA scientists have found the first evidence that a specific form of estrogen can protect the brain from degeneration yet not increase the risk for estrogen-induced cancers of the breast and uterus. The study took place in mice infected with the animal equivalent of multiple sclerosis. [click link for full article] - [Read more] |
| Barrs Portia(R) Generic Oral Contraceptive Approved And Launched In Canada
August 29, 2007 07:00:00Barr Pharmaceuticals, Inc. (NYSE: BRL) announced that its subsidiary, Barr Laboratories, Inc., has received approval from the Therapeutic Products Directorate (TPD) of Health Canada for its Abbreviated New Drug Submission (ANDS) for its Portia(R) generic oral contraceptive as a generic equivalent of Wyeth Laboratories Min-Ovral(R) Tablets. This represents the first approval of a generic oral contraceptive for Canadian consumers. [click link for full article] - [Read more] |
| Indevus Announces Submission Of New Drug Application
August 29, 2007 07:00:00Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for NEBIDO(R) (testosterone undecanoate) intramuscular injection, a long-acting testosterone therapy intended to treat male patients with primary and secondary hypogonadism. [click link for full article] - [Read more] |
| Is It Safe To Use Oral Contraceptives To Eliminate Periods? Harvard Womens Health Watch Explores The
August 28, 2007 07:00:00The new birth control pill Lybrel is the first oral contraceptive designed to be taken 365 days a year with no pill-free intervals. Women who use Lybrel dont have regular periods, although they may have breakthrough bleeding. There are risks and benefits to suppressing menstruation, reports the September 2007 issue of Harvard Womens Health Watch. The idea of preventing periods is not completely new. [click link for full article] - [Read more] |
| MI Seems to Be a Risk Factor for Diabetes
August 24, 2007 12:33:12BOSTON -- Myocardial infarction more than doubles the risk of new-onset diabetes and leads to a 15-fold increased risk of impaired fasting glucose, results of a study of more than 8,000 MI patients show. - [Read more] |
| Estrogens Secret Role In Obesity Revealed
August 24, 2007 12:00:00New research on the effects of the female sex hormone estrogen in the brain lend credence to what many women have suspected about the hormonal changes that accompany aging: Menopause can make you fat.Scientists long have sought to understand how changes in hormones during menopause could account for the increase in appetite and accompanying weight gain that often occurs among aging women. [click link for full article] - [Read more] |
| 1 In 15 Women Affected Worldwide By Polycystic Ovary Syndrome, And Burden Likely To Increase
August 24, 2007 11:00:00The diverse and complex female endocrine disorder polycystic ovary syndrome (PCOS), which affects 1 in 15 women worldwide, is a major economic health burden that is likely to expand together with obesity, conclude authors of a Seminar in this weeks edition of The Lancet. Dr Theresa Hickey and Prof Robert Norman, University of Adelaide, Australia, and colleagues, reviewed published literature on PCOS up to November 2006 to prepare the Seminar. [click link for full article] - [Read more] |
| Viagra Increases Release Of Key Reproductive Hormone
August 24, 2007 07:00:00The little blue pill may do more than get the blood pumping. Sildenafil the generic name for Viagra also increases release of a reproductive hormone in rats, according to a new study.Researchers at the University of Wisconsin-Madison report this month that sildenafil increases the amount of oxytocin released by stimulation of the posterior pituitary gland, a small structure directly underneath the brain that regulates hormone levels in response to neural signals. [click link for full article] - [Read more] |
| QuatRx Completes Patient Enrollment In Phase 3 Study Of Ophena(TM) In Women With Postmenopausal Vagi
August 23, 2007 07:00:00QuatRx Pharmaceuticals, a privately-held biopharmaceutical company focused on development and commercialization of compounds to treat endocrine, metabolic and cardiovascular disorders, today announced that it has completed enrollment of a pivotal Phase 3 clinical trial of Ophena(TM) (ospemifene), the companys estrogen-free oral therapy in development for the treatment of vaginal symptoms associated with menopause. [click link for full article] - [Read more] |
| Risk Factors For Breast Cancer, Dense Breasts And Hormone Levels, Are Separate And Independent
August 22, 2007 21:00:00The density of a womans breast tissue and her level of sex hormones are two strong and independent risk factors for breast cancer, according to a team of researchers from Harvard and Georgetown universities. The finding dispels the common belief that the risk associated with dense breasts merely reflects the same risk associated with high levels of circulating sex hormones, they say. [click link for full article] - [Read more] |
|
|
